Reversible lipid accumulation and associated division arrest of mycobacterium avium in lipoprotein-induced foamy macrophages may resemble key events during latency and reactivation of tuberculosis

Infection and Immunity

Volumn 82, Issue 2, 2014, Pages 476-490

  Caire Brändli, Irène ^a   Papadopoulos, Alexia ^a   Malaga, Wladimir ^b   Marais, David ^c   Canaan, Stéphane ^d   Thilo, Lutz ^c   De Chastelliera, Chantal ^a  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; BACTERIAL CELL; BACTERIAL CELL WALL; BACTERIAL METABOLISM; CELL CYCLE ARREST; CELL DIVISION; CELL INCLUSION; CONTROLLED STUDY; CYTOPLASM; ELECTRON MICROSCOPY; EXPERIMENTAL MODEL; FEMALE; FOAM CELL; FOAMY MACROPHAGE; HOST PATHOGEN INTERACTION; LATENT TUBERCULOSIS; LIPID STORAGE; LIPID TRANSPORT; MACROPHAGE; MEMBRANE FUSION; MOUSE; MYCOBACTERIUM AVIUM; NONHUMAN; PERSISTENT INFECTION; PHAGOSOME; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ANIMALS; CELL DIVISION; CELLS, CULTURED; FEMALE; INCLUSION BODIES; LIPID METABOLISM; LIPOPROTEINS, VLDL; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; MYCOBACTERIUM AVIUM;

EID: 84893020254     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01196-13     Document Type: Article

References (71)

1. World Health Organization. 2011. Global Tuberculosis Report 2011. World Health Organization, Geneva, Switzerland. http://www.who.int/tb /publications/global_report/en/index.html.
2. Glickman MS, Jacobs WR, Jr. 2001. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell 104:477-485. http://dx.doi .org/10.1016/S0092-8674(01)00236-7.
3. Tufariello JM, Chan J, Flynn JL. 2003. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect. Dis. 3:578-590. http://dx.doi.org/10.1016/S1473-3099(03)00741-2.
4. Russell DG. 2001. Mycobacterium tuberculosis: here today, and here tomorrow. Nat. Rev. Mol. Cell Biol. 2:569-577. http://dx.doi.org/10.1038 /35085034.
5. Russell DG, Cardona PJ, Kim MJ, Allain S, Altare F. 2009. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat. Immunol. 10:943-948. http://dx.doi.org/10.1038/ni.1781.
6. de Chastellier C. 2009. The many niches and strategies used by pathogenic mycobacteria for survival within host macrophages. Immunobiology 214:526-542. http://dx.doi.org/10.1016/j.imbio.2008.12.005.
7. Thilo L, de Chastellier C. 2004. Phagosome biogenesis in relation to intracellular survival mechanisms of mycobacteria, p 153-169. In Gorvel JP (ed), Intracellular pathogens in membrane interactions and vacuole biogenesis. R.G. Landes Co, Austin, TX.
8. Murphy DJ. 2001. The biogenesis and functions of lipid bodies in animals, plants and microorganisms. Prog. Lipid Res. 40:325-438. http://dx .doi.org/10.1016/S0163-7827(01)00013-3.
9. Tauchi-Sato K, Ozeki S, Houjou T, Taguchi R, Fujimoto T. 2002. The surface of lipid droplets is a phospholipid monolayer with a unique fatty acid composition. J. Biol. Chem. 277:44507-44512. http://dx.doi.org/10 .1074/jbc.M207712200.
10. van Meer G. 2001. Caveolin, cholesterol, and lipid droplets? J. Cell Biol. 152:F29-F34. http://dx.doi.org/10.1083/jcb.152.5.F29.
11. Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, Bardou F, Daffe M, Emile JF, Marchou B, Cardona PJ, de Chastellier C, Altare F. 2008. Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog. 4:e1000204. http://dx.doi.org/10.1371/journal.ppat.1000204.
12. Barros U, Ladiwala U, Birdi TJ, Antia NH. 1987. Localization and retention of mycobacterial antigen in lymph nodes of leprosy patients. Br. J. Exp. Pathol. 68:733-741.
13. Hunter RL, Jagannath C, Actor JK. 2007. Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs. Tuberculosis (Edinb.) 87:267-278. http://dx.doi.org/10.1016/j.tube.2006.11 .003.
14. Ridley DS, Ridley MJ. 1987. Rationale for the histological spectrum of tuberculosis. A basis for classification. Pathology 19:186-192.
15. Mattos KA, Lara FA, Oliveira VG, Rodrigues LS, D'Avila H, Melo RC, Manso PP, Sarno EN, Bozza PT, Pessolani MC. 2011. Modulation of lipid droplets by Mycobacterium leprae in Schwann cells: a putative mechanism for host lipid acquisition and bacterial survival in phagosomes. Cell. Microbiol. 13:259-273. http://dx.doi.org/10.1111/j.1462-5822.2010.01533.x.
16. Muller H, Kruger S. 1994. Immunohistochemical analysis of cell composition and in situ cytokine expression in HIV- and non-HIV-associated tuberculous lymphadenitis. Immunobiology 191:354-368. http://dx.doi .org/10.1016/S0171-2985(11)80441-9.
17. Cardona PJ, Llatjos R, Gordillo S, Diaz J, Ojanguren I, Ariza A, Ausina V. 2000. Evolution of granulomas in lungs of mice infected aerogenically with Mycobacterium tuberculosis. Scand. J. Immunol. 52:156-163. http: //dx.doi.org/10.1046/j.1365-3083.2000.00763.x.
18. Hernandez-Pando R, Orozco H, Arriaga K, Sampieri A, Larriva-Sahd J, Madrid-Marina V. 1997. Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis. Immunology 90:607-617. http://dx.doi.org/10.1046/j.1365-2567 .1997.00193.x.
19. Rhoades ER, Geisel RE, Butcher BA, McDonough S, Russell DG. 2005. Cell wall lipids from Mycobacterium bovis BCG are inflammatory when inoculated within a gel matrix: characterization of a new model of the granulomatous response to mycobacterial components. Tuberculosis (Edinb.) 85:159-176. http://dx.doi.org/10.1016/j.tube.2004.10.001.
20. Kim MJ, Wainwright HC, Locketz M, Bekker LG, Walther GB, Dittrich C, Visser A, Wang W, Hsu FF, Wiehart U, Tsenova L, Kaplan G, Russell DG. 2010. Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol. Med. 2:258-274. http://dx .doi.org/10.1002/emmm.201000079.
21. Podinovskaia M, Lee W, Caldwell S, Russell DG. 2013. Infection of macrophages with Mycobacterium tuberculosis induces global modifications to phagosomal function. Cell. Microbiol. 15:843-859. http://dx.doi .org/10.1111/cmi.12092.
22. Singh V, Jamwal S, Jain R, Verma P, Gokhale R, Rao KV. 2012. Mycobacterium tuberculosis-driven targeted recalibration of macrophage lipid homeostasis promotes the foamy phenotype. Cell Host Microbe 12: 669-681. http://dx.doi.org/10.1016/j.chom.2012.09.012.
23. Daniel J, Maamar H, Deb C, Sirakova TD, Kolattukudy PE. 2011. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS Pathog. 7:e1002093. http://dx.doi.org/10.1371/journal.ppat .1002093.
24. Neyrolles O, Hernandez-Pando R, Pietri-Rouxel F, Fornes P, Tailleux L, Payan JA, Pivert E, Bordat Y, Aguilar D, Prevost MC, Petit C, Gicquel B. 2006. Is adipose tissue a place for Mycobacterium tuberculosis persistence? PLoS One 1:e43. http://dx.doi.org/10.1371/journal.pone.0000043.
25. Garton N, Christensen H, Minnikin D, Adegbola R, Barer M. 2002. Intracellular lipophilic inclusions of mycobacteria in vitro and in sputum. Microbiology 148:2951-2958.
26. Garton NJ, Waddell SJ, Sherratt AL, Lee SM, Smith RJ, Senner C, Hinds J, Rajakumar K, Adegbola RA, Besra GS, Butcher PD, Barer MR. 2008. Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med. 5:e75. http://dx.doi.org/10.1371 /journal.pmed.0050075.
27. Bhatt A, Fujiwara N, Bhatt K, Gurcha SS, Kremer L, Chen B, Chan J, Porcelli SA, Kobayashi K, Besra GS, Jacobs WR, Jr. 2007. Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice. Proc. Natl. Acad. Sci. U. S. A. 104:5157-5162. http://dx.doi.org/10.1073/pnas.0608654104.
28. Boshoff HI, Barry CE, III. 2005. Tuberculosis - metabolism and respiration in the absence of growth. Nat. Rev. Microbiol. 3:70-80. http://dx.doi .org/10.1038/nrmicro1065.
29. Wayne LG, Sohaskey CD. 2001. Nonreplicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol. 55:139-163. http://dx.doi.org /10.1146/annurev.micro.55.1.139.
30. Wayne LG, Hayes LG. 1996. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64:2062-2069.
31. Daniel J, Deb C, Dubey VS, Sirakova TD, Abomoelak B, Morbidoni HR, Kolattukudy PE. 2004. Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture. J. Bacteriol. 186: 5017-5030. http://dx.doi.org/10.1128/JB.186.15.5017-5030.2004.
32. Low KL, Rao PS, Shui G, Bendt AK, Pethe K, Dick T, Wenk MR. 2009. Triacylglycerol utilization is required for regrowth of in vitro hypoxic nonreplicating Mycobacterium bovis bacillus Calmette-Guerin. J. Bacteriol. 191:5037-5043. http://dx.doi.org/10.1128/JB.00530-09.
33. Puissegur MP, Botanch C, Duteyrat JL, Delsol G, Caratero C, Altare F. 2004. An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells. Cell. Microbiol. 6:423-433. http://dx.doi.org/10.1111/j.1462-5822.2004 .00371.x.
34. Kapoor N, Pawar S, Sirakova TD, Deb C, Warren WL, Kolattukudy PE. 2013. Humangranulomain vitromodel,forTBdormancyandresuscitation.PLoSOne 8:e53657. http://dx.doi.org/10.1371/journal.pone.0053657.
35. Horsburgh CRJ. 1997. Epidemiology of Mycobacterium avium complex disease. Am. J. Med. 102:11-15.
36. Mori M, Itabe H, Higashi Y, Fujimoto Y, Shiomi M, Yoshizumi M, Ouchi Y, Takano T. 2001. Foam cell formation containing lipid droplets enriched with free cholesterol by hyperlipidemic serum. J. Lipid Res. 42: 1771-1781.
37. de Chastellier C, Lang T, Thilo L. 1995. Phagocytic processing of the macrophage endoparasite, Mycobacterium avium, in comparison to phagosomes which contain Bacillus subtilis or latex beads. Eur. J. Cell Biol. 68:167-182.
38. Astarie-Dequeker C, Le Guyader L, Malaga W, Seaphanh FK, Chalut C, Lopez A, Guilhot C. 2009. Phthiocerol dimycocerosates of M. tuberculosis participate in macrophage invasion by inducing changes in the organization of plasma membrane lipids. PLoS Pathog. 5:e1000289. http://dx .doi.org/10.1371/journal.ppat.1000289.
39. Lee SH, Cheung M, Irani V, Carroll JD, Inamine JM, Howe WR, Maslow JN. 2002. Optimization of electroporation conditions for Mycobacterium avium. Tuberculosis (Edinb.) 82:167-174. http://dx.doi.org/10 .1054/tube.2002.0335.
40. Christensen H, Garton N, Horobin R, Minnikin D, Barer M. 1999. Lipid domainsofmycobacteriastudiedwithfluorescentmolecularprobes.Mol.Microbiol. 31:1561-1572. http://dx.doi.org/10.1046/j.1365-2958.1999.01304.x.
41. Wältermann M, Steinbüchel A. 2005. Neutral lipid bodies in prokaryotes: recent insights into structure, formation, and relationship to eukaryotic lipid depots. J. Bacteriol. 187:3607-3619. http://dx.doi.org/10 .1128/JB.187.11.3607-3619.2005.
42. Korf J, Stoltz A, Verschoor J, De Baetselier P, Grooten J. 2005. The Mycobacterium tuberculosis cell wall component mycolic acid elicits pathogen-associated host innate immune responses. Eur. J. Immunol. 35: 890-900. http://dx.doi.org/10.1002/eji.200425332.
43. Deb C, Daniel J, Sirakova TD, Abomoelak B, Dubey VS, Kolattukudy PE. 2006. A novel lipase belonging to the hormone-sensitive lipase family induced under starvation to utilize stored triacylglycerol in Mycobacterium tuberculosis. J. Biol. Chem. 281:3866-3875. http://dx.doi.org/10 .1074/jbc.M505556200.
44. Deb C, Lee CM, Dubey VS, Daniel J, Abomoelak B, Sirakova TD, Pawar S, Rogers L, Kolattukudy PE. 2009. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipidloaded, drug-tolerant, dormant pathogen. PLoS One 4:e6077. http://dx .doi.org/10.1371/journal.pone.0006077.
45. Sirakova TD, Dubey VS, Deb C, Daniel J, Korotkova TA, Abomoelak B, Kolattukudy PE. 2006. Identification of a diacylglycerol acyltransferase gene involved in accumulation of triacylglycerol in Mycobacterium tuberculosis under stress. Microbiology 152:2717-2725. http://dx.doi.org/10 .1099/mic.0.28993-0.
46. Murphy DJ, Vance J. 1999. Mechanisms of lipid-body formation. Trends Biochem. Sci. 24:109-115. http://dx.doi.org/10.1016/S0968-0004(98)01349-8.
47. Saka HA, Valdivia R. 2012. Emerging roles for lipid droplets in immunity and host-pathogen interactions. Annu. Rev. Cell Dev. Biol. 28:411-437. http://dx.doi.org/10.1146/annurev-cellbio-092910-153958.
48. Pandey AK, Sassetti CM. 2008. Mycobacterial persistence requires the utilization of host cholesterol. Proc. Natl. Acad. Sci. U. S. A. 105:4376- 4380. http://dx.doi.org/10.1073/pnas.0711159105.
49. Hadvàry P, Lengsfeld H, Wolfer H. 1988. Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin. Biochem. J. 256:357- 361.
50. Du J, Wang Z. 2009. Therapeutic potential of lipase inhibitor orlistat in Alzheimer's disease. Med. Hypotheses 73:662-663. http://dx.doi.org/10 .1016/j.mehy.2009.04.046.
51. Nelson RH, Miles JM. 2005. The use of orlistat in the treatment of obesity, dyslipidaemia and type 2 diabetes. Expert Opin. Pharmacother. 6:2483- 2491. http://dx.doi.org/10.1517/14656566.6.14.2483.
52. Yang PY, Liu K, Ngai MH, Lear MJ, Wenk MR, Yao SQ. 2010. Activitybased proteome profiling of potential cellular targets of Orlistat-an FDAapproved drug with anti-tumor activities. J. Am. Chem. Soc. 132:656- 666. http://dx.doi.org/10.1021/ja907716f.
53. Daleke MH, Cascioferro A, de Punder K, Ummels R, Abdallah AM, van der Wel N, Peters PJ, Luirink J, Manganelli R, Bitter W. 2011. Conserved Pro-Glu (PE) and Pro-Pro-Glu (PPE) protein domains target LipY lipases of pathogenic mycobacteria to the cell surface via theESX-5pathway. J. Biol.Chem.286:19024- 19034. http://dx.doi.org/10.1074/jbc.M110.204966.
54. Mishra KC, de Chastellier C, Narayana Y, Bifani P, Brown AK, Besra GS, Katoch VM, Joshi B, Balaji KN, Kremer L. 2008. Functional role of the PE domain and immunogenicity of the Mycobacterium tuberculosis triacylglycerol hydrolase LipY. Infect. Immun. 76:127-140. http://dx.doi .org/10.1128/IAI.00410-07.
55. de Chastellier C, Frehel C, Offredo C, Skamene E. 1993. Implication of phagosome-lysosome fusion in restriction of Mycobacterium avium growth in bone marrow macrophages from genetically resistant mice. Infect. Immun. 61:3775-3784.
56. de Chastellier C, Thilo L. 2006. Cholesterol depletion in Mycobacterium avium-infected macrophages overcomes the block in phagosome maturation and leads to the reversible sequestration of viable mycobacteria in phagolysosome-derived autophagic vacuoles. Cell. Microbiol. 8:242-256. http://dx.doi.org/10.1111/j.1462-5822.2005.00617.x.
57. Dhouib R, Ducret A, Hubert P, Carriere F, Dukan S, Canaan S. 2011. Watching intracellular lipolysis in mycobacteria using time lapse fluorescence microscopy. Biochim. Biophys. Acta 1811:234-241. http://dx.doi .org/10.1016/j.bbalip.2011.01.001.
58. Ohsaki Y, Cheng J, Suzuki M, Shinohara Y, Fujita A, Fujimoto T. 2009. Biogenesis of cytoplasmic lipid droplets: from the lipid ester globule in the membrane to the visible structure. Biochim. Biophys. Acta 1791:399-407. http://dx.doi.org/10.1016/j.bbalip.2008.10.002.
59. Dedieu L, Serveau-Avesque C, Kremer L, Canaan S. 2013. Mycobacterial lipolytic enzymes: a gold mine for tuberculosis research. Biochimie 95:66- 73. http://dx.doi.org/10.1016/j.biochi.2012.07.008.
60. Bakala N'goma JC, Schue M, Carriere F, Geerlof A, Canaan S. 2010. Evidence for the cytotoxic effects of Mycobacterium tuberculosis phospholipase C towards macrophages. Biochim. Biophys. Acta 1801:1305-1313. http://dx.doi.org/10.1016/j.bbalip.2010.08.007.
61. Schué M, Maurin D, Dhouib R, N'Goma JC, Delorme V, Lambeau G, Carriere F, Canaan S. 2010. Two cutinase-like proteins secreted by Mycobacterium tuberculosis show very different lipolytic activities reflecting their physiological function. FASEB J. 24:1893-1903. http://dx.doi.org/10 .1096/fj.09-144766.
62. West NP, Chow FM, Randall EJ, Wu J, Chen J, Ribeiro JM, Britton WJ. 2009. Cutinase-like proteins of Mycobacterium tuberculosis: characterization of their variable enzymatic functions and active site identification. FASEB J. 23:1694-1704. http://dx.doi.org/10.1096/fj.08-114421.
63. de Chastellier C, Forquet F, Gordon A, Thilo L. 2009. Mycobacterium requires an all-around closely apposing phagosome membrane to maintain the maturation block and this apposition is re-established when it rescues itself from phagolysosomes. Cell. Microbiol. 11:1190-1207. http: //dx.doi.org/10.1111/j.1462-5822.2009.01324.x.
64. de Chastellier C, Thilo L. 1997. Phagosome maturation and fusion with lysosomes in relation to surface property and size of the phagocytic particle. Eur. J. Cell Biol. 74:49-62.
65. Pietersen R, Thilo L, de Chastellier C. 2004. Mycobacterium tuberculosis and Mycobacterium avium modify the composition of the phagosomal membrane in infected macrophages by selective depletion of cell surfacederived glycoconjugates. Eur. J. Cell Biol. 83:153-158. http://dx.doi.org /10.1078/0171-9335-00370.
66. Dedieu L, Serveau-Avesque C, Canaan S. 2013. Identification of residues involved in substrate specificity and cytotoxicity of two closely related cutinases from Mycobacterium tuberculosis. PLoS One 8:e66913. http: //dx.doi.org/10.1371/journal.pone.0066913.
67. Côtes K, Dhouib R, Douchet I, Chahinian H, de Caro A, Carriere F, Canaan S. 2007. Characterization of an exported monoglyceride lipase from Mycobacterium tuberculosis possibly involved in the metabolism of host cell membrane lipids. Biochem. J. 408:417-427. http://dx.doi.org/10 .1042/BJ20070745.
68. Dhouib R, Laval F, Carriere F, Daffe M, Canaan S. 2010. A monoacylglycerol lipase from Mycobacterium smegmatis involved in bacterial cell interaction. J. Bacteriol. 192:4776-4785. http://dx.doi.org/10.1128/JB.00261-10.
69. Honer zu Bentrup K, Russell DG. 2001. Mycobacterial persistence: adaptation to a changing environment. Trends Microbiol. 9:597-605. http://dx.doi.org/10.1016/S0966-842X(01)02238-7.
70. McKinney JD, Honer zu Bentrup K, Munoz-Elias EJ, Miczak A, Chen B, Chan WT, Swenson D, Sacchettini JC, Jacobs WR, Jr, Russell DG. 2000. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406:735-738. http://dx.doi.org/10.1038/35021074.
71. Haeusser DP, Levin PA. 2008. The great divide: coordinating cell cycle events during bacterial growth and division. Curr. Opin. Microbiol. 11: 94-99. http://dx.doi.org/10.1016/j.mib.2008.02.008.